Table 2: Demographic and clinical characteristics of the sample.

Characteristic Baseline
(N=76)
Follow-up
(N=71)
P value*
Age (years), mean (SD) 50.9 (11.3) 53.2 (11.9) N/A
Female, n (%) 68 (89.5) 63 (88.7) N/A
Non-Hispanic/Latino, n (%) 72 (94.7) 67 (94.4) N/A
Employed for pay, n (%) 25 (32.9) 19 (26.8) 0.157
Annual household income, n (%) 0.335
       Under $20,000 19 (25.0) 24 (33.8)
       $20,000 to $44,999 26 (34.2) 17 (23.9)
       $45,000 to $64,999 11 (14.5) 10 (14.1)
       $65,000 to $89,999 11 (14.5) 14 (19.7)
       $90,000 to $124,999 6 (7.9) 3 (4.2)
       $125,000 or more 3 (3.9) 3 (4.2)
Health insurance, n (%) 58 (76.3) 59 (83.1) 0.157
Prescription drug insurance, n (%) 58 (76.3) 57 (80.3) 0.317
Body mass index, n (%) 0.172
       Underweight (< 18.50 kg/m2) 3 (3.9) 0 (0.0)
       Normal (18.50 to 24.99 kg/m2) 14 (18.4) 13 (18.3)
       Overweight (25.00 to 29.99 kg/m2) 12 (15.8) 17 (23.9)
       Obese (≥ 30 kg/m2) 47 (61.8) 41 (57.7)
Time since fibromyalgia diagnosis (years), mean (SD) 4.1 (7.0) 6.2 (7.0) N/A
Number of comorbid conditions, mean (SD) 5.1 (2.9) 4.8 (2.6) 0.240

Abbreviations: N/A, not applicable; SD, standard deviation.
* While descriptive statistics are provided for all available patients, P values are only presented for the 71 patients who completed these questions at both time points, where applicable.
N=76 at Baseline and Follow-up. Patients who reported being diagnosed prior to Baseline were reevaluated by the site physician to confirm FM diagnosis. If the prior diagnosis was confirmed, the patient-reported month and year of the initial diagnosis was used. For patients diagnosed for the first time at Baseline (N=44), time since diagnosis was 0.0 months.
For those patients with at least one: N=73 at Baseline and N=67 at Follow-up. Patients answered the following question regarding FM-related comorbid conditions: “Please indicate if you have been diagnosed or are currently being treated for any of the following conditions and symptoms.” Listed FM-related comorbid conditions included arthritis, depression, irritable bowel syndrome, and sleep apnea, among others.